Chronic Diabetic Foot Ulcers
2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Lakewood-AmedexFL - University Park
1 program1
5% Bisphosphocin Topical GelPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Tides MedicalDual Layer Amniotic Membrane
Oneness BiotechON101 Cream
Lakewood-Amedex5% Bisphosphocin Topical Gel
Clinical Trials (3)
Total enrollment: 139 patients across 3 trials
Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)
Start: Sep 2020Est. completion: Mar 2023124 patients
Phase 4Unknown
Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
Start: Jul 2021Est. completion: Nov 202212 patients
Phase 3Terminated
Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer
Start: Mar 2022Est. completion: Jun 20223 patients
Phase 2Terminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.